References
Moorhead JF, Wheeler CD, Varghese Z (1989) Glomerular structures and lipids in progressive renal disease. Am J Med 87: 5N-12N
D'Amico G, Gentile MG (1991) Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients. Kidney Int 39 [Suppl 31]: S65-S69
Crepaldi G, Avogaro P, Descovich GC, Di Perri T, Postiglione A, Sirtori CR, Strano A, Ventura S, Musatti L (1988) Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Atherosclerosis 70: 115–121
Becker M, Staab D, Von Bergmann K (1992) Treatment of severe familial hypercholestrolemia in children: effect of sitosterol and bezafibrate. Pediatrics 89: 138–142
Stein EA (1989) Treatment of familial hypercholesterolemia with drugs in children. Atheros: lerosis [Suppl] 8: 145–151
Hattori M, Ito K, Kawaguchi H, Tanaka T, Kubota R, Khono M (1993) Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis. Pediatr Nephrol 7: 196–198
Hirano T, Morohoshi T (1992) Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis. Nephron 60: 443–447
Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L (1987) Beneficial effects of combined colestipolniacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257: 3233–3240
Diamond JR, Karnovsky MJ (1988) Editorial review: focal segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 33: 917–924
Author information
Authors and Affiliations
Additional information
The editors invite questions for this section
Rights and permissions
About this article
Cite this article
Querfeld, U. Ask the expert. Pediatr Nephrol 7, 702 (1993). https://doi.org/10.1007/BF01213326
Issue Date:
DOI: https://doi.org/10.1007/BF01213326